Related Experiment Videos
Carcinoma of the anal canal--radiation or radiation plus chemotherapy?
International Journal of Radiation Oncology, Biology, Physics
|September 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cumulative Impacts and COVID-19: Implications for Low-Income, Minoritized, and Health-Compromised Communities in King County, WA.
Journal of racial and ethnic health disparities·2021
Community-Level Factors Associated with COVID-19 Cases and Testing Equity in King County, Washington.
International journal of environmental research and public health·2020
Health impact assessment of urban waterway decisions.
International journal of environmental research and public health·2014
A senescence-driven fibroblast-macrophage feed-forward circuit promotes radiation induced cutaneous fibrosis.
International journal of radiation oncology, biology, physics·2026
Harmonizing Radiotherapy Data Standards: A Comparative Analysis of OMOP, CDISC, FHIR, NAACCR, and OBO Foundry with an O3-Anchored Mapping Framework.
International journal of radiation oncology, biology, physics·2026
PET-Guided Dose Escalation for Stage III Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
International journal of radiation oncology, biology, physics·2026
Organ Preservation With Total Neoadjuvant Therapy (OPTNT) for Early Low Rectal Cancer: Short-Term Outcomes of a Nonrandomized Phase 2 Clinical Trial.
International journal of radiation oncology, biology, physics·2026
Escalation of Resting Heart Rate and Tachycardia as a Response to Thoracic Radiotherapy: Implications for Cardiovascular Outcomes after Radiotherapy.
International journal of radiation oncology, biology, physics·2026
Concurrent Versus Sequential Postoperative Radiotherapy and CDK4/6 Inhibitors in Breast Cancer with Positive Regional Nodes: A Multi-Center Safety and Toxicity Study.
International journal of radiation oncology, biology, physics·2026
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026